Printer Friendly

Familial Exudative Retinopathy: A Case and Family Analysis.

Introduction

Familial exudative vitreoretinopathy (FEVR) is a rare hereditary disease affecting retinal vascular development, and was first described in 1969 by Criswick and Schepens. (1) The vascular pathologies were characterized by Canny and Oliver (2) in 1976 using fundus fluorescein angiography (FFA). The primary clinical manifestation of the disease is an avascular peripheral retina. Subsequent ischemia may lead to other findings of FEVR, including serious problems such as neovascularization (NVE), fibrosis, posterior pole traction, retinal folds, and even retinal detachment. (3) Diagnosis can be made based on the presence of these findings on fundus examination, but evaluation of family members can also support the diagnosis in advanced cases with complicated findings. Ranchod et al. (4) and Pendergast and Trese. (5) reported positive family history in 37% and 57.7% of patients with FEVR, respectively. In a study conducted in Turkey, 7 out of 10 patients were found to have a positive family history. (6) In this report, we present the findings of a patient diagnosed with FEVR and another affected member of his family.

Case Report

A 49-year-old male patient was referred to our clinic with a prediagnosis of retinal vascular occlusion. In his medical history, he reported developing low vision after a traffic accident in childhood, having laser treatment in both eyes at 12 years of age and again 1 month earlier, and undergoing bilateral laser-assisted in situ keratomileusis in 2002. His medical and family histories were otherwise unremarkable. Following fundus examination and FFA, he was questioned again about his birth and he stated that he had been born full term by normal delivery. On ophthalmologic examination, his visual acuity was 0.4 in the right eye and 0.3 in the right eye, with mild cortical lens opacities. Fundus photography showed straightening of the temporal retinal vascular arcades and temporal dragging of the macula in both eyes (Figure 1).

Previously applied laser spots with corresponding preretinal fibrosis were observed in the temporal periphery. Although the nonperfused areas in the temporal retina had been partially laser treated, FFA revealed leakage due to persistent retinal NVE in the right eye (Figure 2).

Optical coherence tomography revealed disrupted macular contour associated with epiretinal membrane in the right macula and minimal perifoveal thinning in the left macula (Figure 3).

Suspecting FEVR, the patient's family members were invited for ophthalmologic examination. The patient's father had normal ocular findings, while his brother showed straightening of the temporal vascular arcades in both eyes and excessive vascular branching and nonperfusing cord vessels in the peripheral vasculature, as well as temporal avascular areas (Figure 4).

His brother was also not born prematurely. FFA was not performed for his brother because he did not return for the procedure. FFA in the patient's father was within normal limits. Based on the brother's findings and the revised Pendergast and Trese (7) classification, the patient was diagnosed with stage 2A FEVR and his brother was diagnosed with stage 1A FEVR (Table 1). The patient's other family members did not appear for examination. Additional laser therapy to the nonperfused areas was recommended due to persistent NVE. When obtaining his family history, it was learned that his parents were second-degree cousins.

Discussion

FEVR is diagnosed clinically. In the early stages, it is important to differentiate FEVR from retinopathy of prematurity. However, in older patients presenting with findings such as proliferative vitreoretinopathy (PVR), retinal detachment, and vitreous hemorrhage, especially those with asymmetric involvement, pathologies such as Coats disease, Eales disease, retinosis, sickle cell anemia, and toxocariasis must be excluded. Patients may also present with various combinations of macular dragging, radial retinal folds, NVE, preretinal vitreous organization, vitreoretinal proliferation, subretinal exudation, and retinal detachment. PVR is more common in advanced disease, and requires multiple surgical interventions. (8)

Milder forms of FEVR may manifest with peripheral avascularity accompanied by vitreoretinal adhesions, venovenous anastomoses, increased vascular branching, and V-shaped retinochoroidal degeneration. Some FEVR patients who are asymptomatic with approximately normal fundus examination are reported to have smaller optical disc diameter, greater optic disc-macular distance/optic disc diameter ratio, and higher vessel density from the optic disc compared to a control group. (10) We also observed these findings in the patient's brother. These findings may support a diagnosis of FEVR in suspected cases.

To date, mutations in 5 genes have been associated with the AEVR phenotype (NDP, FZD4, LRP5, TSPAN12, ZNF408). (11,12) Autosomal recessive, autosomal dominant, and X-related inheritance patterns have been reported. Therefore, while patients may have a positive family history, a negative family history may not be significant because family members can exhibit different clinical severity. One of the main challenges to diagnosis is that the patient's parents are often healthy. The examination of other family members, especially siblings, is important to prevent further suffering associated with the disease. (13) Because FEVR carries the risk of blindness, screening family members not only facilitates diagnosis, but is also key for follow-up and future genetic counseling for these patients. In addition, evaluating family members can expand our knowledge of the clinical course of the various phenotypes of this rare condition. Our patient had undergone laser therapy at another center and was undiagnosed when he was referred to our clinic. His family members were evaluated for this purpose for the first time and FEVR was detected in his brother. Because we could not perform genetic analysis in this case, the affected gene and inheritance pattern could not be determined, but the patient's family was made aware of the possible complications and genetic transmission of this disease.

FEVR can present in older patients. Family screening assists diagnosis and also enables affected individuals to be identified before becoming symptomatic. These individuals can be informed about and followed for the possible complications of the disease. Furthermore, inheritance pattern may be determined based on the affected family members and genetic counseling can be provided for future generations.

Ethics

Informed Consent: The patient's consent was not received because this case report is retrospective and any information that will reveal the patient's identity is not shared.

Peer-review: Externally and internally peer-reviewed.

Authorship Contributions

Surgical and Medical Practices: Feray Koc, Hazan Gul Kahraman, Concept: Feray Koc, Design: Feray Koc, Data Collection or Processing: Feray Koc, Hazan Gu Kahraman, Analysis or Interpretation: Feray Koc, Hazan Gul Kahraman, Nazife Sefi Yurdakul, Literature Search: Feray Koc, Hazan Giil Kahraman, Writing: Feray Koc, Hazan Giil Kahraman.

Conflict of Interest: No conflict of interest was declared by the authors.

Financial Disclosure: The authors declared that this study received no financial support.

References

(1.) Criswick VG, Schepens CL. Familial exudative vitreoretinopathy. Am J Ophthalmol 1969;68:578-594.

(2.) Canny CL, Oliver GL. Fluorescein angiographic findings in familial exudative vitreoretinopathy Arch Ophthalmol. 1976;94:1114-1120.

(3.) Gilmour DF Familial exudative vitreoretinopathy and related retinopathies. Eye (Lond). 2015;29:1-14.

(4.) Ranchod TM, Ho LY, Drenser KA, Capone A Jr, Trese MT. Clinical presentation of familial exudative vitreoretinopathy Ophthalmology 2011;118:2070-2075.

(5.) Pendergast SD, Trese MT. Familial exudative vitreoretinopathy Results of surgical management. Ophthalmology 1998;105:1015-1023.

(6.) Cebeci Z, Yildiz Ekinci D, Bayraktar S, Kir N. Familial exudative vitreoretinopathy: Follow-up and treatment results. Turk J Ophthalmol. 2014;44:370-373.

(7.) Kashani AH, Brown KT, Chang E, Drenser KA, Capone A, Trese MT Diversity of retinal vascular anomalies in patients with familial exudative vitreoretinopathy Ophthalmology 2014; 121:2220-2227.

(8.) Aktan G, Subasi M, Or M, Akbatur H. Results of treatment of familial exudative vitreoretinopathy Annals of Ophthalmology 2000;32:212-218.

(9.) Sizmaz S, Yonekawa Y, Trese MT Familial exudative vitreoretinopathy Turk J Ophthalmol. 2015;45:164-168.

(10.) Yuan M, Yang Y, Yu S, Hu A, Lu L, Ma J, Ding XI, Li J. Posterior pole retinal abnormalities in mild asymptomatic FEVR. Invest Ophthalmol Vis Sci 20l4l6;56:458-463.

(11.) Kaderli B. Familyal eksiidatif vitreoretinopati. Ret-Vit. 2012;20:120-124.

(12.) Chen ZY, Battinelli EM, Fielder A, Bundy's, Sims K, Breakefield XO, Craig IW A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy Nat Genet. 1993;5:180-183.

(13.) Collin WW, Nikopoulos K, Dona M, Gilissen C, Hoischen A, Boonstra FN, Poulter JA, Kondo H, Berger W, Toomes C, Tahira T, Mohn LR, Blokland EA, Hetterschijt L, Ali M, Groothuismink JM, Duijkers L, Inglehearn CF, Sollfrank L, Strom TM, Uchio E, van Nouhuys CE, Kremer H, Veltman JA, van Wijk E, Cremers FP ZNF408 is mutated in familial exudative vitreoretinopathy and is crucial for the development of zebraflsh retinal vasculature. Proc Natl Acad Sci USA. 2013;110:9856-9861.

iD Hazan Gul Kahraman, iD Feray Koc, iD Nazife Sefi Yurdakul

Izmir Ataturk Training and Research Hospital, Ophthalmology Clinic, Izmir, Turkey

DOI: 10.4274/tjo.03185
COPYRIGHT 2018 Galenos Yayinevi Tic. Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Case Report
Author:Kahraman, Hazan Gul; Koc, Feray; Yurdakul, Nazife Sefi
Publication:Turkish Journal of Ophthalmology
Date:Jul 1, 2018
Words:1435
Previous Article:Intravitreal Aflibercept as an Adjunct to Systemic Therapy in a Case of Choroidal Neovascular Membrane Associated with Sympathetic Ophthalmia.
Next Article:In Vivo Confocal Microscopy Analysis of the Corneal Layers in Adenoviral Epidemic Keratoconjunctivitis.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters